Fantastic to be working with so many Thacher alums to develop the new medical field of immuno-autonomics – especially our new Inmedix VP of Corporate Development, Stuart Hwang, PhD ’78. I could not be more appreciative of their support and confidence to help Inmedix, Inc. and subsidiary Inmedix UK Ltd. make a difference for patients with autoimmune diseases and cancer.
Andrew Holman CdeP 1977